ALGS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aligos Therapeutics Inc

NASDAQ | ALGS

9.87

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$56.67M

Market Cap

-

P/E Ratio

-13.31

EPS

$46.80

52 Week High

$3.76

52 Week Low

HEALTHCARE

Sector

ALGS Chart

Recent Chart
Price Action

ALGS Technicals

Tags:

ALGS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

Revenue & Profitability

Earnings Performance

ALGS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $70M
Total Current Assets $62M
Cash And Cash Equivalents At Carrying Value $37M
Cash And Short Term Investments $37M
Inventory -
Current Net Receivables -
Total Non Current Assets $8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $20M
Other Current Assets $5.2M
Other Non Current Assets -
Total Liabilities $99M
Total Current Liabilities $22M
Current Accounts Payable $2.6M
Deferred Revenue -
Current Debt -
Short Term Debt $3.5M
Total Non Current Liabilities $79M
Capital Lease Obligations $8.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.4M
Other Current Liabilities $16M
Other Non Current Liabilities $46K
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$618M
Common Stock $8K
Common Stock Shares Outstanding $6.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$81M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.6M
Capital Expenditures $130K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $355K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$131M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

ALGS News

ALGS Profile

Aligos Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aligos Therapeutics, Inc. (ALGS) is a dynamic clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for viral infections and liver diseases. Its extensive pipeline features candidates for chronic hepatitis B and liver fibrosis, underscoring the company's commitment to addressing critical unmet medical needs through advanced scientific approaches and strategic collaborations. Aligos's dedication to pioneering transformative healthcare solutions positions it as a compelling investment opportunity for institutional investors seeking growth in the biopharmaceutical sector.

LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+75.10%
$0.68
IRBT
+73.84%
$3.39
IXHL
+12.68%
$0.44
VHAI
-33.33%
$0.00
NVDA
-1.03%
$179.59
KITT
+115.88%
$1.56
ONDS
+10.53%
$8.92
PLUG
+5.68%
$2.23
NIO
-4.97%
$4.78
TSLA
+4.07%
$446.74
RR
+18.53%
$4.22
INTC
+0.66%
$43.76
IPG
-1.95%
$24.57
ASST
+1.44%
$1.05
BYND
-3.10%
$1.25
BITF
+0.32%
$3.11
VALE
+3.18%
$13.30
AXDX
-61.36%
$0.03
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
CAPR
+371.06%
$29.96
BMNR
+5.48%
$33.66
NFLX
-4.92%
$103.96
MRVL
+7.86%
$100.20
SOFI
-1.49%
$29.07
PFE
+1.67%
$25.57
ADAP
-15.14%
$0.05
BBD
-2.35%
$3.58
ACHR
+9.15%
$8.35
DNN
+4.24%
$2.70
F
+1.00%
$13.09
INHD
-6.65%
$0.13
AAPL
-0.71%
$284.15
SOND
-23.45%
$0.12
MARA
+4.70%
$12.47
KVUE
+0.65%
$16.97
BMNU
+10.08%
$8.08
GOOGL
+1.20%
$319.63
RMBL
+60.50%
$3.21
QBTS
+11.46%
$25.08
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BAC
+1.69%
$54.09
BTBT
+4.01%
$2.33
AMZN
-0.87%
$232.38
CLSK
+5.68%
$14.49
SRM
+53.27%
$10.30
GRAB
+0.19%
$5.27
RGTI
+9.04%
$26.04
MSFT
-2.50%
$477.73
PCG
-0.58%
$15.23
CIFR
+5.61%
$18.63
RIVN
+1.74%
$17.53
GOOG
+1.45%
$320.62
PLTR
+3.15%
$176.08
WULF
+1.47%
$14.43
WLGS
-5.57%
$0.04
PLTD
-3.30%
$6.73
AMD
+1.09%
$217.60
MTSR
-0.35%
$70.50
HBAN
+2.89%
$17.04
T
-0.78%
$25.32
RIG
-0.91%
$4.31
BMY
+5.61%
$50.96
MSTR
+3.89%
$188.39
BTG
+1.58%
$4.50
SMR
+6.50%
$20.14
SNAP
+0.52%
$7.66
HOOD
+6.10%
$133.64
WMT
+1.77%
$114.41
AUR
+13.03%
$4.51
ASBP
-10.81%
$0.08
CHR
-6.96%
$0.04
AFMD
-34.94%
$0.18
NOK
+1.13%
$6.26
FCX
+3.63%
$44.53
MCHP
+12.16%
$63.61
WBD
+0.16%
$24.57
IMRN
-10.91%
$1.55
CMG
-0.61%
$33.93
GTLB
-12.77%
$37.83
PMAX
+25.55%
$2.85
ITUB
+0.38%
$7.92
M
-1.10%
$22.46
CMND
-14.27%
$0.11
PSTG
-27.29%
$68.87
UBER
+3.55%
$90.68
CRCL
+11.42%
$86.29
APLD
+4.67%
$29.36
TWOH
0.00%
$0.00
CGC
+4.50%
$1.16
AVGO
-0.25%
$380.61
AMCR
+0.71%
$8.46
SOUN
+4.99%
$11.78
VZ
+0.14%
$40.67
CRWV
+4.37%
$79.36
VIVK
-13.34%
$0.09
RXRX
+7.87%
$4.66
LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+75.10%
$0.68
IRBT
+73.84%
$3.39
IXHL
+12.68%
$0.44
VHAI
-33.33%
$0.00
NVDA
-1.03%
$179.59
KITT
+115.88%
$1.56
ONDS
+10.53%
$8.92
PLUG
+5.68%
$2.23
NIO
-4.97%
$4.78
TSLA
+4.07%
$446.74
RR
+18.53%
$4.22
INTC
+0.66%
$43.76
IPG
-1.95%
$24.57
ASST
+1.44%
$1.05
BYND
-3.10%
$1.25
BITF
+0.32%
$3.11
VALE
+3.18%
$13.30
AXDX
-61.36%
$0.03
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
CAPR
+371.06%
$29.96
BMNR
+5.48%
$33.66
NFLX
-4.92%
$103.96
MRVL
+7.86%
$100.20
SOFI
-1.49%
$29.07
PFE
+1.67%
$25.57
ADAP
-15.14%
$0.05
BBD
-2.35%
$3.58
ACHR
+9.15%
$8.35
DNN
+4.24%
$2.70
F
+1.00%
$13.09
INHD
-6.65%
$0.13
AAPL
-0.71%
$284.15
SOND
-23.45%
$0.12
MARA
+4.70%
$12.47
KVUE
+0.65%
$16.97
BMNU
+10.08%
$8.08
GOOGL
+1.20%
$319.63
RMBL
+60.50%
$3.21
QBTS
+11.46%
$25.08
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BAC
+1.69%
$54.09
BTBT
+4.01%
$2.33
AMZN
-0.87%
$232.38
CLSK
+5.68%
$14.49
SRM
+53.27%
$10.30
GRAB
+0.19%
$5.27
RGTI
+9.04%
$26.04
MSFT
-2.50%
$477.73
PCG
-0.58%
$15.23
CIFR
+5.61%
$18.63
RIVN
+1.74%
$17.53
GOOG
+1.45%
$320.62
PLTR
+3.15%
$176.08
WULF
+1.47%
$14.43
WLGS
-5.57%
$0.04
PLTD
-3.30%
$6.73
AMD
+1.09%
$217.60
MTSR
-0.35%
$70.50
HBAN
+2.89%
$17.04
T
-0.78%
$25.32
RIG
-0.91%
$4.31
BMY
+5.61%
$50.96
MSTR
+3.89%
$188.39
BTG
+1.58%
$4.50
SMR
+6.50%
$20.14
SNAP
+0.52%
$7.66
HOOD
+6.10%
$133.64
WMT
+1.77%
$114.41
AUR
+13.03%
$4.51
ASBP
-10.81%
$0.08
CHR
-6.96%
$0.04
AFMD
-34.94%
$0.18
NOK
+1.13%
$6.26
FCX
+3.63%
$44.53
MCHP
+12.16%
$63.61
WBD
+0.16%
$24.57
IMRN
-10.91%
$1.55
CMG
-0.61%
$33.93
GTLB
-12.77%
$37.83
PMAX
+25.55%
$2.85
ITUB
+0.38%
$7.92
M
-1.10%
$22.46
CMND
-14.27%
$0.11
PSTG
-27.29%
$68.87
UBER
+3.55%
$90.68
CRCL
+11.42%
$86.29
APLD
+4.67%
$29.36
TWOH
0.00%
$0.00
CGC
+4.50%
$1.16
AVGO
-0.25%
$380.61
AMCR
+0.71%
$8.46
SOUN
+4.99%
$11.78
VZ
+0.14%
$40.67
CRWV
+4.37%
$79.36
VIVK
-13.34%
$0.09
RXRX
+7.87%
$4.66
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.